Title | Date | Formats | |
---|---|---|---|
Device Bioresearch Monitoring: Perspectives | 5/25/05 | PPT | Text |
What’s Happening with Pediatric Medical Devices? | 5/25/05 | PPT | Text |
CDRH Electronic SubmissionsTurbo 510(k) forIn Vitro Diagnostic Devices | 5/25/05 | PPT | Text |
Conditions of Approval Studies: the CDRH Perspective | 5/25/05 | PPT | Text |
Scheduling Pre-Market Inspections | 5/25/05 | PPT | Text |
HDEs, Humanitarian Use Designations (HUDs), and the Office of Orphan Products | 5/25/05 | PPT | Text |
Understanding the Pre-IDE Program: FDA Perspective | 5/25/05 | PPT | Text |
PMA Guidance Updates | 5/24/05 | PPT | Text |
OIVD Highlights | 5/24/05 | PPT | Text |
Using the Third Party Review Program | 5/24/05 | PPT | Text |
What a Great 510(k) Should Look Like | 5/24/05 | PPT | Text |
Reprocessing of Single Use Devices | 5/24/05 | PPT | Text |
Turbo 510(k) and Beyond | 5/24/05 | PPT | Text |
Report from ODE - AdvaMed 15th Annual Device Submission Workshop | 5/24/05 | PPT | Text |
Critical Path Initiative In Medical Devices - AdvaMed Submissions Workshop | 5/24/05 | PPT | Text |
CDRH Update 2005 - 8th Annual FDA-OCRA Educational Conference | PPT | Text | |
Postmarket Surveillance: Medical Devices | 4/8/05 | PPT | Text |
Early/Expanded Access Provisions for Unapproved/Investigational Medical Devices | 4/8/05 | PPT | Text |
CDRH Update - Facilitating Medical Device Innovation and Technology | 4/8/05 | PPT | Text |
New FDA Guidelines for Medical Devices | 4/1/05 | PPT | Text |
CDRH: A Vision for 2005 and Beyond - MassMEDIC's FDA Update | 12/04 | PPT | Text | |
Improving the Availability of Pediatric Devices - American Academy of Pediatrics - Washington DC | 6/28/04 | Text | ||
FDLI Conference: FDA Regulation of Genomic and Genetic Diagnostic Devices | 4/16/04 | PPT | Text | |
FDLI Conference: Device Issues | 4/16/04 | PPT | Text | |
FDLI Conference: The Division of Bioresearch Monitoring Case Studies | 4/16/04 | PPT | Text | |
FDLI Conference: EPA/FDA Regulatory Partnerships and Partitions | 4/16/04 | PPT | Text | |
FDLI Conference: Custom Devices | 4/16/04 | PPT | Text | |
FDLI Conference: Ombudsman | 4/16/04 | PPT | Text | |
AdvaMed Submissions Workshop - Medical Devices: Innovation
and Regulation |
6/5/03 | PPT | Text | |
FDA's CLIA Complexity Process | 4/23/02 | PPT | Text | |
Estimated Benefits of Proposed Amendments to the FDA Radiation-Safety Standard for Diagnostic X-Ray Equipment | 12/31/01 | PPT | Text | |
Evaluating Breakthrough Technology: An FDA Perspective | 06/15/2001 | PPT | Text | |
CLIA Update: June 5, 2001 | 06/05/2001 | PPT | ||
FDA's Final Policy on Single-Use Devices Reprocessed by Hospitals and Commercial Reprocessors | 05/10/2001 05/30/2001 |
PPT | Text | |
MDMA Presentation - CDRH: Looking Ahead | 05/18/2001 | PPT | ||
FDLI Presentation: Closing Gaps in Our Postmarket Safety Net for Medical Devices: It’s Everybody’s Business! | 04/18/2001 | PPT | Text | |
FDLI Presentation: CDRH - Looking Ahead | 04/18/2001 | PPT | ||
Estimated Benefits of Proposed Amendments to the FDA Radiation-Safety Standard for Diagnostic X-Ray Equipment | 02/15-16/2001 | PPT | Text | |
Gaps in Your Postmarket Safety Net for Medical Devices | 1/8/2001 | PPT | Text | |
CDRH Executive Briefing - RAPS Annual Meeting | 10/2000 | PPT | ||
Device Regulation in an International Milieu | 9/25/2000 | PPT | ||
Polyvinyl Chloride and DEHP | 9/20/2000 | PPT | ||
Global Challenges in Human Factors and Medical Systems Mini-symposia | 8/2/2000 | PPT | ||
CDRH Overview | 7/18/2000 | PPT | ||
Future Trends | 7/19/2000 | PPT | ||
Role of the CDRH Ombudsman | 7/2000 | PPT | ||
The FDA Modernization Act | 6/29/2000 | PPT | ||
CDRH Update - MDMA | 6/12/2000 | PPT | ||
AAMI 2000 Conference and Expo | 6/6/2000 | PPT | ||
CDRH Update - FDLI | 6/5/2000 | PPT | ||
FDA and the Reuse of Single Use Devices: Policy Moving Forward - FASA Presentation | 5/6/2000 | PPT | ||
Staff Update: The Least Burdensome Provisions of FDAMA | 4/2/2000 | PPT | ||
CDRH: Moving Forward | 3/23/2000 | PPT | ||
The Role of Standards at CDRH | 3/15/2000 | PPT | ||
Patient Safety: Emerging Opportunities in the Health Care System | 3/2000 | PPT | ||
Statement By David W. Feigal, M.D. Director, CDRH, Before The Subcommittee On Oversight And Investigations Committee On Commerce U.S. House Of Representatives | 2/10/2000 | Text | ||
Part 11 News and Views - Electronic Records and Electronic Signatures Regulation | 1/13/2000 | PPT | ||
CDRH Update | 12/16/1999 | PPT | ||
The Least Burdensome Provisions of the FDA Modernization Act of 1997 - Training for CDRH Advisory Panels | 12/99 | PPT | ||
The Least Burdensome Provisions of the FDA Modernization Act of 1997 | 12/13/1999 | PPT | ||
CDRH Top Priorities 2000 | 12/10/1999 | PPT | ||
Standards of Evidence for Drug Approvals | 12/9/1999 | PPT | ||
Assessment of the Quality of Life Impact of Medical Devices | 11/4/1999 | PPT | ||
Current Issues for Medical Devices | 11/2/1999 | PPT | ||
Pharmacogenomics: A regulatory perspective | 10/28/1999 | PPT | ||
Least Burdensome Pathway to Market | 10/25/1999 | PPT | ||
Protein PK/PD A Regulatory Perspective | 10/19/1999 | PPT | ||
Current Issues for Medical Devices in the U.S. | 10/12/1999 | PPT | ||
CDRH Executive Briefing | 10/4/1999 | PPT | ||
CDRH Update | 9/27/1999 | PPT | ||
QSIT Corrective and Preventive Actions | various | PPT | ||
QSIT: Design Controls and Production and Process Controls | various | PPT | ||
QSIT Management Controls | various | PPT | ||
The Quality System Inspection Technique: QSIT | various | PPT | ||
QSIT: Compliance Program and Warning Letter Pilot | various | PPT | ||
CDRH Directions | 7/27/1999 | PPT | ||
FDLI Medical Device Update | 6/29/1999 | PPT | ||
Medical Device User Fees | 5/25/1999 | PPT |
Updated July 21, 2005
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH